General metabolic intoxication in patients with COPD. Dynamics of metabolic intoxication severity on a background of tiotropium bromide (TB) treatment

T. Pertseva, O. Gurzhiy, O. Lykholat (Dnepropetrovsk, Ukraine)

Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Session: Biomarkers and disease assessment in COPD
Session type: E-Communication Session
Number: 3116
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Pertseva, O. Gurzhiy, O. Lykholat (Dnepropetrovsk, Ukraine). General metabolic intoxication in patients with COPD. Dynamics of metabolic intoxication severity on a background of tiotropium bromide (TB) treatment. Eur Respir J 2008; 32: Suppl. 52, 3116

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of tiotropium bromide on IFN-γ level: Results from 180-days study in moderate COPD patients with viral-induced exacerbations in anamnesis
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016

Efficacy of tiotropium bromide inhalation combined with or without low dose theophylline for moderate to severe stable Chinese COPD patients
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013

The effect of tiotropium bromide on lung function parameters in patients with asthma- COPD overlap syndrome
Source: International Congress 2016 – Asthma points to ponder
Year: 2016


Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level
Source: International Congress 2014 – COPD markers
Year: 2014

Effect of tiotropium bromide on collagen-IV level: Results from 180-days study in subjects with moderate COPD
Source: International Congress 2014 – Markers
Year: 2014

Estimation of tiotropium efficacy at the COPD patients with group D
Source: International Congress 2015 – Different data in COPD
Year: 2015


Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013


Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Evaluation of mucociliary clearance‘s (MCC) condition in patients with COPD. Influence of tiotropium bromide (TB) on MCC
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Changes in inhalation therapy after combined assessment of COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015


Physical status and dependence levels in patients with COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD)
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes
Source: International Congress 2015 – Different data in COPD
Year: 2015


The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Effect of salmeterol/fluticasone propionate versus tiotropium bromide on withdrawal rate, health status, lung function and mortality: INSPIRE (investigating new standards for prophylaxis in reduction of exacerbations) study
Source: Eur Respir J 2007; 30: Suppl. 51, 34s
Year: 2007

Influence of tiotropium bromide (TB) on mucociliary clearance (MCC) in patients with COPD
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009


COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014

COPD assessment test (CAT) in acute exacerbation of COPD and in the long term follow up of COPD patients
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


The adherence to inhaled drugs in COPD patients: Effect on survival
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015